Phase II Trial of FOLFOXIRI + Bevacizumab in Patients With Untreated Metastatic Colorectal Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2018
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms BeTRI
- 18 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 13 Jul 2016 Planned End Date changed from 1 Mar 2018 to 1 Sep 2018.
- 13 Jul 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Sep 2018.